Radiology resident compiles staging database

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 12
Volume 17
Issue 12

CHICAGO-When Roland Talanow, MD, PhD, began his radiology residency, the topic of cancer staging proved to be particularly confounding. In an effort to educate himself and help others, Dr. Talanow has built a free, Web-based database that offers one-stop shopping on cancer staging, including comprehensive information on lymphoma, non-Hodgkin’s lymphoma, and HIV-related lymphoma. Dr. Talanow showcased his Web site, www.cancerstaging.info, at RSNA 2008 (abstract LLR03001-H).

CHICAGO-When Roland Talanow, MD, PhD, began his radiology residency, the topic of cancer staging proved to be particularly confounding. In an effort to educate himself and help others, Dr. Talanow has built a free, Web-based database that offers one-stop shopping on cancer staging, including comprehensive information on lymphoma, non-Hodgkin’s lymphoma, and HIV-related lymphoma. Dr. Talanow showcased his Web site, www.cancerstaging.info, at RSNA 2008 (abstract LLR03001-H).

“I wanted to create a communication tool that would provide a better way to access staging information,” Dr. Talanow told Oncology News International. He is currently a fourth year resident at the Cleveland Clinic. “The main focus of the site is as an education tool for radiologists, but I hope it also benefits clinicians. I wanted to provide a better interface between radiologists and other specialists,” he said.

The Web offers users a “simple version” that hits the highlights of the disease state as well as an “extended version” that includes American Joint Cancer Commission (AJCC) classification information. The lymphoma section, for example, also offers clinical and histological findings and a staging subclassification system. Each section is rounded out with linked references and standard treatment options. Finally, there is a list of latest publications on a topic generated through PubMed Reader.

The link to www.cancerstaging.info can also be exported to a desktop. Registration is required but is free. Dr. Talanow said that he plans to update the site at least once a year and that he welcomes user input.

Recent Videos
STX-478 showed efficacy in patients with advanced solid tumors regardless of whether they had kinase domain or helical PI3K mutations.
Lisa J. States, MD, discussed further steps for improving early detection and screening methods in patients with Li–Fraumeni syndrome.
STX-478 may avoid adverse effects associated with prior PI3K inhibitors that lack selectivity for the mutated protein vs the wild-type protein.
9 Experts are featured in this series.
9 Experts are featured in this series.
Additional genetic testing measures and targeted therapies may improve outcomes for patients with diverse molecular subgroups of gastric cancers.
Phase 1 data may show the possibility of rationally designing agents that can preferentially target PI3K mutations in solid tumors.
Funding a clinical trial to further assess liquid biopsy in patients with Li-Fraumeni syndrome may help with detecting cancers early across the board.
4 KOLs are featured in this series.
Related Content